Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
| Brand name | LISINOPRIL |
| Generic name | LISINOPRIL |
| Active ingredient(s) | LISINOPRIL |
| Distributed by / for | Lupin Pharmaceuticals Inc. |
| NDC | 68001-334-08 |
| Full product label | Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product was distributed to OH and may have been further distributed throughout the United States. |
| Quantity | 11,688 bottles |
| Recall initiated | 2020-07-17 |
| Report date | 2020-08-05 |
| Recall completed | 2021-08-26 |
| Recall number | D-1413-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗